Amphastar Pharmaceuticals (AMPH) News Today $44.61 -0.45 (-1.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Los Angeles Capital Management LLC Takes $785,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Los Angeles Capital Management LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 16,169 shares of the coNovember 16 at 4:24 AM | marketbeat.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 5,000 Shares of StockNovember 14 at 8:36 AM | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of StockNovember 9, 2024 | insidertrades.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 7,426 SharesNovember 9, 2024 | insidertrades.comWilliam J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) CFO William J. Peters sold 7,426 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.05, for a total transaction of $386,523.30. Following the transaction, the chief financial officer now owns 94,103 shares in the company, valued at approximately $4,898,061.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.November 8, 2024 | marketbeat.comNeedham Remains a Hold on Amphastar Pharmaceuticals (AMPH)November 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Reports Strong Q3 2024 ResultsNovember 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | insidermonkey.comAmphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?November 7, 2024 | marketbeat.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...November 7, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to ExpectNovember 5, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.comStockNews.com cut Amphastar Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Friday.November 1, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Trims Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Allspring Global Investments Holdings LLC trimmed its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 40.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,263 shares of the company's stocNovember 1, 2024 | marketbeat.comInternational Assets Investment Management LLC Invests $11.07 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)International Assets Investment Management LLC bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 22,809 shares of thOctober 31, 2024 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports.October 30, 2024 | marketbeat.comEyePoint Pharmaceuticals’ Positive Clinical Data Boosts Buy Rating Amid Promising Eye Disease TherapiesOctober 29, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Reduces Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Assenagon Asset Management S.A. lessened its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 11.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 167,355 shares of the company's stock after sellingOctober 29, 2024 | marketbeat.comBoston Trust Walden Corp Acquires Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Boston Trust Walden Corp bought a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 539,639 shares of the company's stock, valOctober 27, 2024 | marketbeat.comAmphastar: Objectively Undervalued But For Good Reason (Rating Downgrade)October 25, 2024 | seekingalpha.comAnalysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)October 24, 2024 | markets.businessinsider.comMoody Aldrich Partners LLC Purchases 44,606 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Moody Aldrich Partners LLC increased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 80.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,340 shares of the company's stock after buyinOctober 24, 2024 | marketbeat.comAmphastar Pharm Shows Rising Relative Strength; Still Shy Of Key BenchmarkOctober 18, 2024 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by StockNews.com to "Buy"StockNews.com raised Amphastar Pharmaceuticals from a "hold" rating to a "buy" rating in a report on Friday.October 18, 2024 | marketbeat.comIBD Rating Upgrades: Amphastar Pharm Flashes Improved Relative Price StrengthOctober 16, 2024 | msn.comAmphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?October 16, 2024 | finance.yahoo.comShort Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Rises By 5.3%Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 4,350,000 shares, a growth of 5.3% from the September 15th total of 4,130,000 shares. Based on an average daily volume of 364,500 shares, the days-to-cover ratio is currently 11.9 days. Approximately 12.0% of the company's stock are short sold.October 16, 2024 | marketbeat.comIs Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?October 11, 2024 | insidermonkey.comStockNews.com Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) to HoldStockNews.com cut shares of Amphastar Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Thursday.October 10, 2024 | marketbeat.comSG Americas Securities LLC Invests $1.71 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)SG Americas Securities LLC purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 35,234 shares of the company's stock, valued at aOctober 9, 2024 | marketbeat.comAmphastar Pharma (NASDAQ:AMPH) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comImplied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock OptionsOctober 4, 2024 | msn.comMillennium Management LLC Buys 338,653 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Millennium Management LLC lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 84.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 738,748 shares of the company's stock afterOctober 3, 2024 | marketbeat.comAmphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2October 2, 2024 | gurufocus.comAurora Investment Counsel Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Aurora Investment Counsel acquired a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 54,466 sharOctober 1, 2024 | marketbeat.comMarshall Wace LLP Buys Shares of 227,127 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Marshall Wace LLP purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 227,127 shares of the company'sSeptember 30, 2024 | marketbeat.comIntech Investment Management LLC Invests $426,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Intech Investment Management LLC acquired a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 10,658 shares ofSeptember 28, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Epoch Investment Partners Inc.Epoch Investment Partners Inc. boosted its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 35.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,078,852 shares of the company's stock after acquiring an additional 280,390 shares durinSeptember 23, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Holdings Lowered by Renaissance Technologies LLCRenaissance Technologies LLC trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 10.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 537,700 shares of the companSeptember 21, 2024 | marketbeat.comGranite Investment Partners LLC Raises Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Granite Investment Partners LLC raised its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 12.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 397,514 shares of tSeptember 20, 2024 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Teva Pharmaceutical (TEVA) and Adicet Bio (ACET)September 19, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returnsSeptember 19, 2024 | finance.yahoo.comAmerican Century Companies Inc. Purchases 121,764 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)American Century Companies Inc. boosted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 19.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 740,408 shares of the company's stock afSeptember 19, 2024 | marketbeat.comVictory Capital Management Inc. Has $7.88 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Victory Capital Management Inc. trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 197,001 shares of the company's stoSeptember 16, 2024 | marketbeat.comFederated Hermes Inc. Has $77.79 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Federated Hermes Inc. cut its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 6.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,944,800 shares of the company's stock after sSeptember 14, 2024 | marketbeat.comAmphastar Pharmaceuticals Offers Interesting Growth And Income ProspectsSeptember 13, 2024 | seekingalpha.comAmphastar: Perplexing Pipeline, Lumpy Revenues - I'm On SidelinesSeptember 12, 2024 | seekingalpha.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset ManagementLSV Asset Management lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 64.2% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 80,400 shares of the company's stock after selling 144,368 shares duringSeptember 12, 2024 | marketbeat.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 3,000 Shares of StockSeptember 7, 2024 | insidertrades.com Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address How one pattern has averaged an 85% return per year since the pandemic. (Ad)Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern… Follow this link here and enter your email address to sign up… AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼0.630.55▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼54▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTGX News Today SNDX News Today CALT News Today PAHC News Today ESPR News Today ENTA News Today ROIV News Today VKTX News Today LEGN News Today ASND News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMPH Stock Alerts